InvestorsHub Logo
Followers 33
Posts 5264
Boards Moderated 0
Alias Born 01/23/2019

Re: couldbebetter post# 417023

Tuesday, 10/24/2023 6:51:36 PM

Tuesday, October 24, 2023 6:51:36 PM

Post# of 424194
CCB, IF Brave top line results are positive, consider this scenario, the jocking around of Denners partner, Susan Langer, to be appointed to Biogens board and Biogens progress to get their alzheimers drug ins. coverage be a possible fit for a Vascepa acquisition ? Just saying.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News